SCHEMBL272038

SCHEMBL272038

CC1CNCC(C)N1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31469886 1.00
SCHEMBL20746172 1.00
SCHEMBL13014875 1.00
SCHEMBL63773 1.00
SCHEMBL2917615 1.00
SCHEMBL1189649 1.00
Hydrochloric Acid SCHEMBL34474911 0.97 ALDH1A1 (0.34)
Hydrochloric Acid SCHEMBL1117277 0.97 ALDH1A1 (0.34)
Hydrochloric Acid SCHEMBL15547550 0.97 ALDH1A1 (0.34)
Hydrochloric Acid SCHEMBL15558585 0.97 ALDH1A1 (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 357 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109302846-B Indolinone compounds and their use in the treatment of fibrotic diseases 莱斯彼维特有限公司 2021-05-11 CN claimed
US-20190337929-A1 INDOLINONES COMPOUNDS AND THEIR USE IN THE TREATMENT OF FIBROTIC DISEASES RESPIVERT LIMITED (GB) 2019-11-07 US claimed
CN-109302846-A Indolinone compounds and their use in the treatment of fibrotic diseases 莱斯彼维特有限公司 2019-02-01 CN claimed
EP-2204394-B1 PROCESS FOR PRODUCTION OF POLYESTER-CONTAINING FLEXIBLE POLYURETHANE FOAM, AND CATALYST COMPOSITION FOR USE IN THE PROCESS TOSOH CORP (JP) 2017-07-12 EP claimed
EP-2589601-B1 COMPOUND FOR INHIBITING TYPE 5 PHOSPHODIESTERASE AND PREPARATION METHOD THEREOF SUZHOU MAIDIXIAN PHARMACEUTICAL INC (CN) 2015-09-09 EP claimed
US-8859565-B2 Compound for inhibiting type 5 phosphodiesterase and preparation method thereof ZHANG NAN (CN) 2014-10-14 US claimed
US-20130116265-A1 COMPOUND FOR INHIBITING TYPE 5 PHOSPHODIESTERASE AND PREPARATION METHOD THEREOF ZHANG NAN (CN) 2013-05-09 US claimed
EP-2589601-A1 COMPOUND FOR INHIBITING TYPE 5 PHOSPHODIESTERASE AND PREPARATION METHOD THEREOF Suzhou Maidixian Pharmaceutical Inc. (CN) 2013-05-08 EP claimed
US-20100256249-A1 METHOD FOR PRODUCING POLYESTER TYPE FLEXIBLE POLYURETHANE FOAM, AND CATALYST COMPOSITION TO BE USED THEREFOR TOSOH CORPORATION (JP) 2010-10-07 US claimed
EP-1591443-B1 PYRAZOLE DERIVATIVE DAIICHI SANKYO CO LTD (JP) 2010-08-25 EP claimed
EP-2204394-A1 PROCESS FOR PRODUCTION OF POLYESTER-CONTAINING FLEXIBLE POLYURETHANE FOAM, AND CATALYST COMPOSITION FOR USE IN THE PROCESS Tosoh Corporation (JP) 2010-07-07 EP claimed
US-7622471-B2 Pyrazole derivatives having a pyridazine and pyridine functionality DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2009-11-24 US claimed
US-20060189591-A1 Five-membered heterocyclic derivative DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2006-08-24 US claimed
US-20060128685-A1 Pyrazole derivative DAIICHI PHARMACEUTICAL CO., LTD., (JP) 2006-06-15 US claimed
EP-1621537-A1 FIVE-MEMBERED HETEROCYCLIC DERIVATIVE DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2006-02-01 EP claimed
EP-1591443-A1 PYRAZOLE DERIVATIVE DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2005-11-02 EP claimed
CN-117886824-B 2, 3-Dihydropyrimido [4,5-d ] pyrimidine-4 (1H) -ketone derivative, preparation method and application thereof 四川大学华西医院 2026-05-15 CN disclosed
EP-4683934-A1 SYSTEM OXFORD UNIVERSITY INNOVATION LIMITED (GB) 2026-01-28 EP disclosed
WO-1993001181-A1 SUBSTITUTED INDOLES AS ANTI-AIDS PHARMACEUTICALS THE UPJOHN COMPANY (US) 1993-01-21 WO disclosed
US-5055581-A Dehydrochlorination reaction between n-alkyl substituted piperazine and bis(-chloroalkyl) ether; useful for urethane forming reaction SAN-APRO LIMITED (JP) 1991-10-08 US disclosed